Marc A. Vooijs
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Development of a rapid ex vivo tumor platform for drug response prediction in lung cancer.
Journal: NPJ precision oncology
Published: February 23, 2026
Normoxic HIFα-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity.
Journal: Cancer & metabolism
Published: January 21, 2026
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis.
Journal: Journal of neuro-oncology
Published: August 22, 2025
Disruption of iron metabolism resulting from Dmt1/Slc11a2 deficiency compromises Notch protein degradation and transcriptional activation.
Journal: The FEBS journal
Published: August 01, 2025
Key Mechanisms in Lysosome Stability, Degradation and Repair.
Journal: Molecular and cellular biology
Published: May 09, 2025
The prognostic and predictive value of peripheral immune-related proteins in patients with lung cancer treated with radiotherapy.
Journal: Frontiers in oncology
Published: May 08, 2025
Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas.
Journal: Oncogenesis
Published: March 25, 2024
Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer.
Journal: British journal of cancer
Published: February 12, 2024
A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 18, 2024
Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity.
Journal: Neuro-oncology advances
Published: December 22, 2023
Last Updated: 09/26/2026